Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

MiniMed Group, Inc. (MMED) Stock Price & Analysis

71 Followers

MMED Stock Chart & Stats

$17.99$0.11(0.64%)
At close: 4:00 PM EST
$17.5$20$22.5Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$17.65 - $18.15
52-Week Range
$10.65 - $24.43
Previous Close
$17.88
Volume
N/A
Average Volume (3M)
14.31M
Market Cap
$5.13B
Enterprise Value
$4.92B
Total Cash (Recent Filing)
$207.00M
Total Debt (Recent Filing)
$59.00M
Price to Earnings (P/E)
―
Beta
0.58
Next Earnings
Nov 24, 2026 (Est.)
EPS Estimate
0.12
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Rapid Revenue Growth

Rapid top-line expansion indicates strong demand and widening adoption across MiniMed’s diabetes-management products. Sustained growth can improve operating leverage, support continued investment in innovation, and strengthen the company’s competitive position over the next several quarters.

Recurring Revenue Base

The large recurring-revenue contribution from consumables and CGM creates an economically valuable installed-base model. Higher attachment rates can deepen customer retention, increase revenue visibility, and support durable growth as pump users continue purchasing related supplies.

Low Leverage And Product Pipeline

Conservative leverage preserves financial flexibility while the expanding product roadmap provides multiple avenues for future growth. New pumps, sensors and algorithms may broaden the addressable market, reinforce ecosystem engagement, and help MiniMed fund development without excessive balance-sheet strain.

Bears Say

Widening Net Losses

Persistent and widening net losses show that strong revenue growth has not yet translated into durable bottom-line profitability. If costs continue rising faster than revenue, the company may have less capacity to self-fund innovation and could face greater pressure to improve execution.

Negative Cash Generation

Negative operating and free cash flow indicate that the current growth model is consuming substantial cash rather than funding expansion internally. Continued cash burn increases dependence on liquidity and successful execution, particularly if losses or investment needs remain elevated.

Margin And Separation Headwinds

A lower-margin product mix can weigh on gross profitability as Simplera expands, while the lengthy transition away from Medtronic service agreements adds execution complexity. These factors may delay margin normalization and make the path to consistent profitability less predictable.

MiniMed Group, Inc. News

MMED FAQ

What was MiniMed Group, Inc.’s price range in the past 12 months?
MiniMed Group, Inc. lowest stock price was $10.65 and its highest was $24.43 in the past 12 months.
What is MiniMed Group, Inc.’s market cap?
MiniMed Group, Inc.’s market cap is $5.13B.
When is MiniMed Group, Inc.’s upcoming earnings report date?
MiniMed Group, Inc.’s next earnings report is estimated for Nov 24, 2026 (not yet confirmed), which is in 10 days.
How were MiniMed Group, Inc.’s earnings last quarter?
MiniMed Group, Inc. released its earnings results on Sep 01, 2026. The company reported $0 earnings per share for the quarter, missing the consensus estimate of $0.124 by -$0.124.
Is MiniMed Group, Inc. overvalued?
According to Wall Street analysts MiniMed Group, Inc.’s price is currently Undervalued.
Does MiniMed Group, Inc. pay dividends?
MiniMed Group, Inc. does not currently pay dividends.
What is MiniMed Group, Inc.’s EPS estimate?
MiniMed Group, Inc.’s EPS estimate is 0.12.
How many shares outstanding does MiniMed Group, Inc. have?
MiniMed Group, Inc. has 281,349,950 shares outstanding.
What happened to MiniMed Group, Inc.’s price movement after its last earnings report?
MiniMed Group, Inc. reported an EPS of $0 in its last earnings report, missing expectations of $0.124. Following the earnings report the stock price went up 10.661%.
Which hedge fund is a major shareholder of MiniMed Group, Inc.?
Hedge funds hold MiniMed Group, Inc. shares: the largest hedge-fund position in MiniMed Group, Inc. is 71,885,854 shares, and hedge funds increased their holdings by 2.2M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology